oncolytic virus

Woburn, Massachusetts | April 10, 2026 Replimune Group Inc. has announced that the U.S. Food and Drug Administration (FDA)...

SUZHOU, China, February 26, 2026 ImmVira Group announced encouraging preliminary clinical data for its oncolytic virus candidate MVR-T3011 in...

CALGARY, Alberta, November 4, 2025 — Oncolytics Biotech® Inc. (NASDAQ: ONCY; TSX: ONC) announced the formation of a Gastrointestinal...